Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/133117
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: The cystic fibrosis gut as a potential source of multidrug resistant pathogens
Author: Taylor, S.L.
Leong, L.E.X.
Sims, S.K.
Keating, R.L.
Papanicolas, L.E.
Richard, A.
Mobegi, F.M.
Wesselingh, S.
Burr, L.D.
Rogers, G.B.
Citation: Journal of Cystic Fibrosis, 2020; 20(3):413-420
Publisher: Elsevier BV
Issue Date: 2020
ISSN: 1569-1993
1873-5010
Statement of
Responsibility: 
Steven L. Taylor, Lex E.X. Leong, Sarah K. Sims, Rebecca L. Keating, Lito E. Papanicolas, Alyson Richard, Fredrick M. Mobegi, Steve Wesselingh, Lucy D. Burr, Geraint B. Rogers
Abstract: Background: The emergence of multidrug resistant (MDR) pathogens represents a profound threat to global health. Individuals with CF have amongst the highest cumulative antibiotic exposure of any pa- tient group, including to critically-important last-line agents. While there is little evidence that antibiotic resistance in airway pathogens results in worse clinical outcomes for CF patients, the potential emergence of MDR pathogens in non-respiratory systems, as a consequence of CF care, represents a potential health threat to the wider population, including family and carers. Methods: Stool from 19 adults with CF and 16 healthy adult controls was subjected to metagenomic sequencing, to assess faecal resistome, and culture-based analysis. Resistant isolates were identified phe- notypically, and genetic determinants of resistance characterised by whole genome sequencing. Results: CF and control faecal resistomes differed significantly ( P = 0.0 0 03). The proportion of reads that mapped to mobile genetic elements was significantly higher in CF ( P = 0.014) and the composition was significantly different ( P = 0.0 0 01). Notably, CF patients displayed higher carriage of plasmid-mediated aminoglycoside-modifying genes ant (6)-Ib, aac (6 ′ )-Ip, and aph (3 ′ )-IIIa ( P < 0.01). Culture-based analy- sis supported higher aminoglycoside resistance, with a higher proportion of aminoglycoside-resistant, Gram-negative bacteria ( P < 0.0 0 01). Isolated extended spectrum beta lactamase (ESBL)-positive Es- cherichia coli from CF stool exhibited phenotypic resistance to tobramycin and gentamicin. Genomic anal- ysis showed co-localisation of both aminoglycoside resistance and ESBL genes, consistent with MDR emer- gence through horizontal gene transfer. Conclusions: The carriage of potentially transmissible resistance within the adult CF gut microbiome is considerably greater than in healthy individuals and could contribute to the emergence and dissemination of MDR pathogens.
Keywords: Anti-bacterial agents; Microbiota; Drug resistance; Resistome; Cystic fibrosis
Rights: © 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
DOI: 10.1016/j.jcf.2020.11.009
Grant ID: http://purl.org/au-research/grants/nhmrc/GNT1155179
Published version: http://dx.doi.org/10.1016/j.jcf.2020.11.009
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.